Xeris Biopharma

XERS · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 29 days ago

Total Revenue

$85.8M

Previous year: $60.1M

+42.8%

EPS

$0.07

Previous year: -$0.03

-333.3%

Total Revenue Growth YoY

42.8%

Recorlev Revenue Growth YoY

Previous year: $47.9M

+56.3%

Cash and Equivalents

$111M

Previous year: $71.6M

Loading...

Xeris Biopharma

Unlock previous datapoints

Upgrade

Xeris Biopharma

Unlock previous datapoints

Upgrade

Xeris Biopharma Revenue by Segment

Revenue by Segment

Recorlev Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Gvoke Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Keveyis Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Royalty, contract & other Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$931M

P/E Ratio

-157.43

Sector

N/A

Industry

N/A

52-Week High

$9.89

52-Week Low

$3.93

Total Revenue Growth YoY

42.8%

Recorlev Revenue Growth YoY

100.5%

COGS Change

$16

R&D Expenses Increase

$29

SG&A Expenses Increase

$18

Products

Get in Touch

Resources

Xeris Biopharma

Xeris Biopharma

Xeris Biopharma

Xeris Biopharma Revenue by Segment

Revenue by Segment

Recorlev Revenue

Gvoke Revenue

Keveyis Revenue

Royalty, contract & other Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics